Marco Robello
5PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 10, 2025
Sulfanylbenzamides with Unique Side Chains to Improve Metabolic Stability, Pharmacokinetics, and Anti-HIV Activity.Marco Robello, Riley F Lehman, Daniel H Appella
|Nov 14, 2024
Covalent Modification of p53 by (E)-1-(4-Methylpiperazin-1-yl)-3-(5-nitrofuran-2-yl)prop-2-en-1-one.Kate Brown, Marco Robello, Andrew J Perciaccante
|Jan 22, 2024
Prodrug Strategy Extends the Use of Anti-HIV Sulfanylbenzamides for Application In Vivo.Marco Robello, Herman Nikolayevskiy, Michael T Scerba
|Jul 29, 2022
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: Synthesis and pharmacological effects.Marco Robello, Silvia Salerno, Elisabetta Barresi
|Mar 25, 2021
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities.Marco Robello, Elisabetta Barresi, Emma Baglini
Pageof 1
Frequent Collaborators
3 joint publications
Daniel H Appella
2 joint publications
Elisabetta Barresi
2 joint publications
Sabrina Taliani
2 joint publications
Federico Da Settimo
2 joint publications
Herman Nikolayevskiy
1 joint publications
Silvia Salerno
1 joint publications
Francesca Simorini
1 joint publications
Emma Baglini
1 joint publications
Valeria Poggetti
1 joint publications
Guido Bocci
